Science Explorer Back to mapMap
Discussion
Researcher · IPO Porto · Portugal

Filipa Moita

Filipa Moita publishes mostly in Pathology and Forensic Medicine, Genetics and Oncology, on topics such as Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research and CAR-T cell therapy research.

ORCID 0000-0001-6974-0531 OpenAlex
World rank
#4,869,256
of 7,710,434 ranked researchers
Rank in Portugal
#25,028
of 41,760
Works
22
Citations
136
Citations per work
6.2
h-index
6
i10-index 4Top 85% in Pathology and Forensic Medicine
Filipa Moita

What does Filipa Moita research?

Filipa Moita's work is mostly in Medicine (63%), Immunology and Microbiology (6%).

Health Sciences: 14 works · 63.1% of their workMedicine: 14 works · 63.1% of their workPathology and Forensic Medicine: 6 works · 26.2% of their workGenetics: 3 works · 13.8% of their workOncology: 2 works · 9.2% of their workHematology: 2 works · 7.7% of their workPublic Health, Environmental and Occupational Health: 1 works · 6.2% of their workEverything else: 7 works · 30.7% of their workLife Sciences: 1 works · 6.2% of their workImmunology and Microbiology: 1 works · 6.2% of their workImmunology: 1 works · 6.2% of their workTHEIR WORKFilipa Moita22works
Life Sciences6%Health Sciences63%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1463.1%
  2. Everything else730.7%
    1. Immunology and Microbiology16.2%
  1. 1Pathology and Forensic Medicine26% of their works
  2. 2Genetics14% of their works
  3. 3Oncology9% of their works
  4. 4Hematology8% of their works
  5. 5Public Health, Environmental and Occupational Health6% of their works
  6. 6Immunology6% of their works

Research topics

Which keywords describe Filipa Moita's research?

The keywords of their largest research topics: Rituximab, Lymphoma, Prognostic Factors, Classification, Molecular Profiling, Chronic Lymphocytic Leukemia, Genomic Aberrations and Minimal Residual Disease.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 20 words, with their numbers
  1. Rituximab242 topics
  2. Lymphoma192 topics
  3. Prognostic Factors184 topics
  4. Classification151 topic
  5. Molecular Profiling151 topic
  6. Chronic Lymphocytic Leukemia91 topic
  7. Genomic Aberrations91 topic
  8. Minimal Residual Disease62 topics
  9. Acute Lymphoblastic Leukemia41 topic
  10. CAR T Cells41 topic
  11. Childhood Cancer41 topic
  12. Chimeric Antigen Receptor41 topic
  13. Cutaneous Lymphomas31 topic
  14. Mycosis Fungoides31 topic
  15. AML21 topic
  16. Acute Myeloid Leukemia21 topic
  17. Cryptococcal Disease21 topic
  18. Diagnosis Criteria21 topic
  19. Histoplasmosis21 topic
  20. International Myeloma Working Group21 topic

Where does Filipa Moita work?

Filipa Moita's main affiliation in the publication record is IPO Porto, Portugal.

How many publications and citations does Filipa Moita have?

OpenAlex counts 22 works and 136 citations for Filipa Moita, an h-index of 6, ranking #4,869,256 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Filipa Moita. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.